Mr Daniel Wolf > Kirkland & Ellis LLP > New York, United States > Lawyer Profile
Kirkland & Ellis LLP Offices
601 LEXINGTON AVENUE
NEW YORK, NY 10022
NEW YORK
United States
Mr Daniel Wolf

Position
Daniel focuses on mergers and acquisitions, representing public and private companies and private equity firms in a variety of domestic and international transactions. His transactional experience spans the range of M&A activity, including many significant cross-border and contested transactions, as well as representing boards of directors in activism defense and governance matters. Clients he has represented include Bristol-Myers Squibb, Blackstone Group, Vista Equity Partners, Celanese, Fortive, Avis Budget, Teva Pharmaceutical, GrubHub, Ventas, Akzo Nobel and GSK.
Education
London School of Economics and Political Science, United Kingdom, LLB, 1995, first class honours.
Lawyer Rankings
United States > M&A/corporate and commercial > M&A: large deals ($1bn+)
(Hall of Fame)Representing multinational corporations, financial sponsors, and boards of directors, the Kirkland & Ellis LLP team has vast experience handling cross-border M&A, including complex mergers of equals and hostile takeovers. The firm’s corporate offering is extensive and also encompasses cross-border leveraged buyouts, carve-out transactions, and joint ventures, with Daniel Wolf acting as a key contact for activism defense and general corporate matters. Sarkis Jebejian is experienced with corporate governance and shareholder activism matters, whilst Eric Schiele frequently advises public company boards and special committees on general transactional and hostile takeover matters. David Feirstein is especially knowledgeable on corporate and securities law issues, Jonathan Davis focuses on public and private M&A, and Edward Lee is an expert in assisting with IPOs and spin-offs. All the department’s lawyers are based in New York, including David Klein, who routinely counsels private equity firms and other investors on a wide array of transactional matters.
United States > M&A/corporate and commercial > Shareholder activism
The New York office of Kirkland & Ellis LLP houses a shareholder activism and hostile takeover defense team that is well regarded for handling some of the most complex and high-profile matters in the US market. The firm draws on its wider strength across related departments in M&A, capital markets, ESG, litigation and restructuring to provide strategic advice to prevent costly proxy fights. However, the team is experienced when those contests do arise and has been one of the firms at the forefront of contests under the SEC’s new universal proxy rules. Shaun Mathew is ‘efficient, thoughtful, creative and aggressive‘ in his counsel to a range of well-known companies and board members, with Sarkis Jebejian being another key figure to note. Daniel Wolf is particularly strong in matters arising from M&A. Eric Schiele has left the firm.
Lawyer Rankings
- Hall of Fame United States > M&A/corporate and commercial > M&A: large deals ($1bn+)
- M&A: large deals ($1bn+) United States > M&A/corporate and commercial
- Shareholder activism United States > M&A/corporate and commercial
Top Tier Firm Rankings
- Media, technology and telecoms > Advertising and marketing: litigation
- Finance > Capital markets: high-yield debt offerings
- International trade and national security > CFIUS
- Antitrust > Civil litigation/class actions: defense
- Government > Government relations
- Intellectual property > Copyright
- Dispute resolution > Corporate investigations and white-collar criminal defense
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Energy > Energy litigation: oil and gas
- Energy > Energy transactions: electric power
- Energy > Energy transactions: oil and gas
- Environment > Environment: transactional
- Dispute resolution > General commercial disputes
- Tax > International tax
- Dispute resolution > M&A litigation: defense
- M&A/corporate and commercial > M&A: large deals ($1bn+)
- Intellectual property > Patents: litigation (full coverage)
- M&A/corporate and commercial > Private equity buyouts: large deals ($500m+)
- Investment fund formation and management > Private equity funds (including venture capital)
- Real estate > Real estate
- Finance > Restructuring (including bankruptcy): corporate
- Dispute resolution > Securities litigation: defense
- Media, technology and telecoms > Technology transactions
- Intellectual property > Trade secrets (litigation and non-contentious matters)
- Intellectual property > Trademarks: litigation
- Tax > US taxes: non-contentious
Firm Rankings
- Finance > Capital markets: debt offerings
- Finance > Capital markets: equity offerings
- Antitrust > Cartel
- Energy > Energy regulation: electric power
- Antitrust > Merger control
- Investment fund formation and management > Mutual/registered/exchange-traded funds
- Media, technology and telecoms > Outsourcing
- Intellectual property > Patents: licensing
- Intellectual property > Patents: litigation (International Trade Commission)
- Dispute resolution > Product liability, mass tort and class action - defense: automotive/transport
- Dispute resolution > Product liability, mass tort and class action - defense: consumer products (including tobacco)
- Dispute resolution > Product liability, mass tort and class action - defense: pharmaceuticals and medical devices
- Dispute resolution > Product liability, mass tort and class action - defense: toxic tort
- Real estate > Real estate investment trusts (REITs)
- Energy > Renewable/alternative power
- Government > State attorneys general
- Finance > Structured finance: securitization
- Tax > US taxes: contentious
- Dispute resolution > E-discovery
- Environment > Environment: litigation
- Dispute resolution > Financial services litigation
- Insurance > Insurance: non-contentious
- Media, technology and telecoms > Media and entertainment: litigation
- Media, technology and telecoms > Media and entertainment: transactional
- Finance > Project finance
- Intellectual property > Trademarks: non-contentious (including prosecution, portfolio management and licensing)
- International trade and national security > Customs, export controls and economic sanctions
- Energy > Energy regulation: oil and gas
- Healthcare > Life sciences
- Dispute resolution > Leading trial lawyers
- Dispute resolution > Leading trial lawyers
- Dispute resolution > Leading trial lawyers
- Dispute resolution > Appellate: courts of appeals / Appellate: supreme courts (states and federal)
- Finance > Commercial lending
- M&A/corporate and commercial > Shareholder activism